282 related articles for article (PubMed ID: 21310926)
41. The histone demethylases Jhdm1a/1b enhance somatic cell reprogramming in a vitamin-C-dependent manner.
Wang T; Chen K; Zeng X; Yang J; Wu Y; Shi X; Qin B; Zeng L; Esteban MA; Pan G; Pei D
Cell Stem Cell; 2011 Dec; 9(6):575-87. PubMed ID: 22100412
[TBL] [Abstract][Full Text] [Related]
42. Combined expression levels of KDM2A and KDM2B correlate with nucleolar size and prognosis in primary breast carcinomas.
De Nicola I; Guerrieri AN; Penzo M; Ceccarelli C; De Leo A; Trerè D; Montanaro L
Histol Histopathol; 2020 Oct; 35(10):1181-1187. PubMed ID: 32901907
[TBL] [Abstract][Full Text] [Related]
43. Epstein-Barr Virus Nuclear Antigen 3C Inhibits Expression of
Gillman ACT; Parker G; Allday MJ; Bazot Q
J Virol; 2018 Nov; 92(21):. PubMed ID: 30135119
[TBL] [Abstract][Full Text] [Related]
44. Tip60-dependent acetylation of KDM2B promotes osteosarcoma carcinogenesis.
Shi X; Fan M
J Cell Mol Med; 2019 Sep; 23(9):6154-6163. PubMed ID: 31218831
[TBL] [Abstract][Full Text] [Related]
45. Alternative isoforms of KDM2A and KDM2B lysine demethylases negatively regulate canonical Wnt signaling.
Lađinović D; Pinkas D; Šopin T; Raška O; Liška F; Raška I; Vacík T
PLoS One; 2020; 15(10):e0236612. PubMed ID: 33104714
[TBL] [Abstract][Full Text] [Related]
46. Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential.
Wong P; Iwasaki M; Somervaille TC; So CW; Cleary ML
Genes Dev; 2007 Nov; 21(21):2762-74. PubMed ID: 17942707
[TBL] [Abstract][Full Text] [Related]
47. Lysine demethylase 2 (KDM2B) regulates hippo pathway via MOB1 to promote pancreatic ductal adenocarcinoma (PDAC) progression.
Quan M; Chen Z; Jiao F; Xiao X; Xia Q; Chen J; Chao Q; Li Y; Gao Y; Yang H; Wang L; Cui J
J Exp Clin Cancer Res; 2020 Jan; 39(1):13. PubMed ID: 31941533
[TBL] [Abstract][Full Text] [Related]
48. KDM2 proteins constrain transcription from CpG island gene promoters independently of their histone demethylase activity.
Turberfield AH; Kondo T; Nakayama M; Koseki Y; King HW; Koseki H; Klose RJ
Nucleic Acids Res; 2019 Sep; 47(17):9005-9023. PubMed ID: 31363749
[TBL] [Abstract][Full Text] [Related]
49. KDM2B, an H3K36-specific demethylase, regulates apoptotic response of GBM cells to TRAIL.
Kurt IC; Sur I; Kaya E; Cingoz A; Kazancioglu S; Kahya Z; Toparlak OD; Senbabaoglu F; Kaya Z; Ozyerli E; Karahüseyinoglu S; Lack NA; Gümüs ZH; Onder TT; Bagci-Onder T
Cell Death Dis; 2017 Jun; 8(6):e2897. PubMed ID: 28661478
[TBL] [Abstract][Full Text] [Related]
50. Long noncoding RNA HOTAIR promotes the self-renewal of leukemia stem cells through epigenetic silencing of p15.
Gao S; Zhou B; Li H; Huang X; Wu Y; Xing C; Yu X; Ji Y
Exp Hematol; 2018 Nov; 67():32-40.e3. PubMed ID: 30172749
[TBL] [Abstract][Full Text] [Related]
51. KDM2B/FBXL10 targets c-Fos for ubiquitylation and degradation in response to mitogenic stimulation.
Han XR; Zha Z; Yuan HX; Feng X; Xia YK; Lei QY; Guan KL; Xiong Y
Oncogene; 2016 Aug; 35(32):4179-90. PubMed ID: 26725323
[TBL] [Abstract][Full Text] [Related]
52. Leukemic transformation of hematopoietic progenitors by MLL-GAS7 in the absence of Hoxa7 or Hoxa9.
So CW; Karsunky H; Wong P; Weissman IL; Cleary ML
Blood; 2004 Apr; 103(8):3192-9. PubMed ID: 15070702
[TBL] [Abstract][Full Text] [Related]
53. PBX3 is essential for leukemia stem cell maintenance in MLL-rearranged leukemia.
Guo H; Chu Y; Wang L; Chen X; Chen Y; Cheng H; Zhang L; Zhou Y; Yang FC; Cheng T; Xu M; Zhang X; Zhou J; Yuan W
Int J Cancer; 2017 Jul; 141(2):324-335. PubMed ID: 28411381
[TBL] [Abstract][Full Text] [Related]
54. [Metabolic activation by a histone H3 lysine 36 demethylase, Fbxl10 in leukemogenesis].
Ueda T; Honda H
Seikagaku; 2016 Jun; 88(3):314-21. PubMed ID: 27483949
[No Abstract] [Full Text] [Related]
55. The Epigenetic Factor KDM2B Regulates EMT and Small GTPases in Colon Tumor Cells.
Zacharopoulou N; Tsapara A; Kallergi G; Schmid E; Alkahtani S; Alarifi S; Tsichlis PN; Kampranis SC; Stournaras C
Cell Physiol Biochem; 2018; 47(1):368-377. PubMed ID: 29772566
[TBL] [Abstract][Full Text] [Related]
56. Low HOX gene expression in PML-RARα-positive leukemia results from suppressed histone demethylation.
Rejlova K; Musilova A; Kramarzova KS; Zaliova M; Fiser K; Alberich-Jorda M; Trka J; Starkova J
Epigenetics; 2018; 13(1):73-84. PubMed ID: 29224413
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of cell proliferation and induction of autophagy by KDM2B/FBXL10 knockdown in gastric cancer cells.
Zhao E; Tang C; Jiang X; Weng X; Zhong X; Zhang D; Hou J; Wang F; Huang M; Cui H
Cell Signal; 2017 Aug; 36():222-229. PubMed ID: 28506929
[TBL] [Abstract][Full Text] [Related]
58. FBXL10 contributes to the development of diffuse large B-cell lymphoma by epigenetically enhancing ERK1/2 signaling pathway.
Zhao X; Wang X; Li Q; Chen W; Zhang N; Kong Y; Lv J; Cao L; Lin D; Wang X; Xu G; Wu X
Cell Death Dis; 2018 Jan; 9(2):46. PubMed ID: 29352142
[TBL] [Abstract][Full Text] [Related]
59. Fbxl10/Kdm2b deficiency accelerates neural progenitor cell death and leads to exencephaly.
Fukuda T; Tokunaga A; Sakamoto R; Yoshida N
Mol Cell Neurosci; 2011 Mar; 46(3):614-24. PubMed ID: 21220025
[TBL] [Abstract][Full Text] [Related]
60. Positional cloning and comprehensive mutation analysis identified a novel KDM2B mutation in a Japanese family with minor malformations, intellectual disability, and schizophrenia.
Yokotsuka-Ishida S; Nakamura M; Tomiyasu Y; Nagai M; Kato Y; Tomiyasu A; Umehara H; Hayashi T; Sasaki N; Ueno SI; Sano A
J Hum Genet; 2021 Jun; 66(6):597-606. PubMed ID: 33402700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
